CybeRelease: (OTC: HCCF) Corporation’s New Board Reports Civil Judgment

( CybeRelease, February 24, 2006 ) - Lake Harmony, PA - HEE Corporation (Pink Sheets: HCCF) announces the newly appointed interim Board of Directors reports a Civil Judgment in the amount of $805,750.50 has been entered in Pinellas County, Florida against HEE Corporation and Ronald D. Brooks individually. The judgment is due to a default on a purchase agreement with Mid South Services for a Gulfstream II private passenger jet aircraft. The newly appointed interim Board of Directors is currently investigating to determine what additional problems, litigation and irregularities may exist.

Keith Wiese, newly appointed interim Chairman stated, “We are shocked and disappointed by this unexpected turn of events. We will continue to investigate and report to the shareholders our findings.”

About HEE Corporation

Founded in Hutchinson, Kansas in December 2003, HEE Corporation (OTC PK: HCCF) is a publicly traded company committed to improving the quality of life through the research, development and distribution of products, services and nutraceuticals that address many of the causes of metabolic syndrome. Metabolic syndrome is quickly being recognized by the medical community as one of the most prevalent health conditions in the United States. HPB-84, manufactured in the United States, is currently sold exclusively through www.hpb84.net. It contains a proprietary blend of the following ingredients generally recognized by the FDA as safe (GRAS). Complete company and investor information can be found at the company Web site, www.hee-corp.com.

Forward-Looking and Cautionary Statements:

Statements contained in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, as discussed in the company’s filings with the Securities and Exchange Commission. HEE Corporation undertakes neither intention nor obligation to publicly update or revise any forward-looking statements. HEE Corporation and the HEE Corporation logo are trademarks or registered trademarks. Copyright © 2005. All rights reserved.

CybeRelease Gainers are Netease.com Inc. (Nasdaq: NTES), Terabeam, Inc. (Nasdaq: TRBM), DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) DUSA Pharmaceuticals Inc. (Nasdaq: DUSA), Imperial Sugar Co. (Nasdaq: IPSU) and WPP 2005 PLC (Nasdaq: WPPGY).

CybeRelease Decliners are Merge Healthcare (Nasdaq: MRGE), Nabi Biopharmaceuticals (Nasdaq: NABI) Nabi Biopharmaceuticals (Nasdaq: NABI), Northfield Laboratories Inc. (Nasdaq: NFLD), Worldspace Corporation (Nasdaq: WRSP) Worldspace Corporation (Nasdaq: WRSP) and Salix Pharmaceuticals Ltd. (Nasdaq: SLXP).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $395.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail